24-01-2001 Comments (0)
CopegusInterferon alfa-2bIntron APeg-IntronPegasysPeginterferon alfa-2aPeginterferon alfa-2bRebetolRebetol and Intron A Combination TherapyRebetronRecombinant for InjectionRibavirinRocheSchering PloughSchering-PloughVirazole
Schering-Plough has won the race to bring a pegylated interferon alfaproduct to the US market. The company's…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.